Context Capital Management’s Fibrocell Science Inc. FCSC Stock Holding History

Context Capital Management’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,020	Closed	-$38K	–	41
2016 Q1	$38K	Sell	1,020 -761	-43%	-$30.4K	0.05%	46
2015 Q4	$157K	Sell	1,781 -286	-14%	-$20.5K	0.24%	36
2015 Q3	$119K	Sell	2,067 -120	-5%	-$10.6K	0.22%	31
2015 Q2	$172K	Sell	2,187 -154	-7%	-$10.4K	0.3%	29
2015 Q1	$158K	Buy	2,341 +1,668	+248%	+$107K	0.29%	30
2014 Q4	$26	Buy	+673	New	+$27.2K	0.03%	33

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Context Capital Management's FCSC Position: Q2 2016 in Review

Context Capital Management sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 1,020 shares — an estimated $38K sold.

Context Capital Management first reported a position in FCSC in Q4 2014 and held it in 6 quarters. The position peaked at $172K in Q2 2015. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

Context Capital Management reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
Context Capital Management sold 1,020 Fibrocell Science Inc. shares in Q2 2016, an estimated $38K.
Context Capital Management first reported a position in Fibrocell Science Inc. in Q4 2014 and held it in 6 quarters.
Context Capital Management's Fibrocell Science Inc. position peaked at $172K in Q2 2015.
44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on Context Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.